AK

Abutalib Khan

Active Director Director DIN 03022887
DIN 03022887 First appointment Apr 2010 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2010
Shareholding value •••• Premium profile

About Abutalib Khan

Data last updated:

Abutalib Khan is a Director at Uniall Pharma Private Limited (since 2010). The company operates in Pharma. Uniall Pharma Private Limited reported revenue of ₹1.53 Cr (FY 2025).

DIN 03022887
Primary Designation Director
Industry Pharma
First Appointment 27 Apr 2010
Oldest Company Age 16 yrs
Largest company Uniall Pharma Private Limited · ₹1.53 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Uniall Pharma Private Limited U15400MH2010PTC202431
Director27 Apr 20102010₹1.53 Cr (FY 2025)Active

Board colleagues of Abutalib Khan

Directorship timeline

Open interactive timeline →
Uniall Pharma Private Limited
Premium access

Shareholding and investment profile for Abutalib Khan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abutalib Khan

Abutalib Khan currently holds 1 directorship: Uniall Pharma Private Limited (Director, since 27 Apr 2010, revenue ₹1.53 Cr (FY 2025)).

Abutalib Khan was first appointed on 27 Apr 2010 as Director at Uniall Pharma Private Limited.

The current boards of Abutalib Khan's companies include Chandrahas Ghodki (Uniall Pharma Private Limited), Deepak Kumar Mishra (Uniall Pharma Private Limited), Jitendra Patel Kumar (Uniall Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available